LOS ANGELES CAPITAL MANAGEMENT LLC - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 130 filers reported holding MERSANA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$250,787
-1.2%
197,470
+219.6%
0.00%0.0%
Q1 2023$253,957
-15.1%
61,790
+21.0%
0.00%0.0%
Q4 2022$299,241
-60.7%
51,065
-54.6%
0.00%
-75.0%
Q3 2022$761,000
-0.9%
112,525
+242.6%
0.00%0.0%
Q2 2020$768,000
+486.3%
32,840
+46.6%
0.00%
+300.0%
Q1 2020$131,00022,4000.00%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sarissa Capital Management LP 4,005,600$64,810,0006.21%
Bain Capital Life Sciences Investors, LLC 3,695,667$59,796,0003.39%
COMMODORE CAPITAL LP 429,228$6,945,0002.77%
ACUTA CAPITAL PARTNERS, LLC 357,689$5,787,0002.09%
Avoro Capital Advisors LLC 6,800,000$110,024,0001.90%
Ghost Tree Capital, LLC 450,000$7,281,0001.71%
RHO CAPITAL PARTNERS INC 796,458$12,887,0001.24%
Rock Springs Capital Management LP 2,775,127$44,902,0000.98%
Sio Capital Management, LLC 157,259$2,544,0000.52%
Bellevue Group AG 2,850,010$46,113,0000.49%
View complete list of MERSANA THERAPEUTICS INC shareholders